Skip to Content
Merck
CN

Key Documents

View All Documentation

EMU072591

MISSION® esiRNA

targeting mouse Sos1

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

NACRES:
NA.51
UNSPSC Code:
41105324
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

ATTGCTCGGCAACTCACTTTACTTGAATCAGATCTATACCGGGCTGTGCAGCCATCAGAATTAGTTGGAAGTGTGTGGACAAAAGAAGATAAAGAAATTAATTCTCCCAACCTTCTGAAGATGATTCGGCACACCACTAACCTCACTTTGTGGTTTGAGAAATGTATTGTAGAAACAGAAAACTTAGAAGAAAGAGTAGCTGTAGTAAGTCGGATAATTGAGATTCTACAAGTCTTTCAAGAGCTGAACAACTTCAATGGTGTCCTGGAAGTTGTCAGTGCTATGAACTCGTCACCTGTTTACAGACTAGACCACACATTTGAGCAAATACCAAGCAGACAAAAGAAAATTTTAGAAGAAGCTCATGAATTGAGTGAAGATCACTATAAGAAATATTTGGCAAAACTCAGGTCTATTAATCCACCGTGTGTGCCT

Ensembl | mouse accession no.

ENSMUSG00000024241

NCBI accession no.

NM_009231

shipped in

ambient

storage temp.

−20°C

Gene Information

mouse ... SOS1(20662), Sos1(20662)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
OXS
DWS

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Li Ren Kong et al.
Molecular cancer therapeutics, 14(7), 1750-1760 (2015-05-06)
Genomic analyses of squamous cell carcinoma (SCC) have yet to yield significant strategies against pathway activation to improve treatment. Platinum-based chemotherapy remains the mainstay of treatment for SCC of different histotypes either as a single-agent or alongside other chemotherapeutic drugs

Global Trade Item Number

SKUGTIN
EMU072591-20UG04061831339390
EMU072591-50UG04061828256563

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service